AIIMS Delhi Research Vacancy

AIIMS Delhi Research Vacancy Available For Pharma – Apply Now

Advertisement for SRF Recruitment

Applications are invited for the post of Senior Research Fellow under the ICMR-funded project as per the details given below:

Project Details

Project title: “Deciphering the Oncogenic network of Ubiquitin specific peptidase 37 (USP37) and its therapeutic potential in prostate cancer”

Senior Research Fellow: One

Principal investigator: Dr. Mayank Singh, Additional Professor

Department: Medical Oncology (Lab), BRAIRCH AIIMS New Delhi 110029

Project Duration: 3 Years

Salary: As per existing guidelines (consolidated)

Essential Qualifications

Qualifications:

Postgraduate degree (MSc) in Life Sciences with two years of research experience in Biochemistry/Biotechnology/Immunology/Molecular Biology. The candidate should have a valid UGC-CSIR NET/GATE/GPAT/DST/DBT/DAE/DOS/DRDO/MHRD score and secured at least 60% marks during post-graduation.

OR

MBBS/BDS/MVSc./M.Pharma/ME/M.Tech degree holders with relevant experience in cancer research

How to Apply:

The application should be submitted their CV, along with the self-attested testimonials and publications to [email protected]. Only the shortlisted candidates will be called for an interview. The date of the interview will be communicated later through email.

Age limit: ≤ 35 years on the last date of the submission of the application.

Last date for application: 29th Feb, 2024

General Instructions

  1. No TA/DA will be paid for appearing in the interview. No other allowances are payable.
  2. No interim request or communication will be entertained.

Keywords: AIIMS Delhi, Senior Research Fellow, ICMR, Life Sciences, Research Vacancy. AIIMS Delhi Research Vacancy Available For Pharma – Apply Now. Subscribe to Rasayanika for the latest chemistry and Pharma job openings, follow us on Facebook and Telegram and subscribe to our youtube channel for the latest updates on chemistry and Pharma jobs and much more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here